Using blood tests to identify bacteria in ICU patients with sepsis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of droplet digital PCR (ddPCR) for detecting pathogenic bacteria in patients diagnosed with sepsis in the ICU. Patients will be monitored for bacterial nucleic acid loads in their blood at various time points until they are either discharged or 28-30 days have passed. The study seeks to establish a correlation between the types and amounts of bacteria present and the patients' clinical outcomes. By doing so, it hopes to improve early identification and ongoing surveillance of infections in critically ill patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with first diagnosis of sepsis after ICU admission

Exclusion Criteria:

* Age under 18 years
* Do not meet Sepsis 3.0 diagnostic criteria
* Refusal to sign informed consent

Where it's running

• Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
  Wuhan, China Recruiting

Study contacts

• Study coordinator: You Shang, prof.
• Email: you_shanghust@163.com
• Phone: 008602785351606

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Syai Tag continuous glucose monitoring for ICU patients

  This will try the Syai Tag continuous glucose monitor in adult ICU patients with arterial lines to see if its readings match standard arterial blood glucose tests.

  Recruiting University Medical Centre Maribor · Maribor · NCT07448805

• Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care

  This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07922213

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• Neutrophil EMR3 as a biomarker for sepsis in ICU patients

  Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT07896018

• Thymalfasin added to standard care for adults with sepsis and immune dysfunction

  This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07866118

• Multicenter group study of sepsis and ARDS in China

  This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.

  Recruiting at 24 sites Shanghai Zhongshan Hospital · Xiamen, Fujian and 23 other locations · NCT07863908

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.